The Birmingham Brief

The Birmingham Brief - intelligent thought on policy issues.

Select Category
Thursday 12th May 2011

Regulating the complementary health professions: is the government doing enough?

Description
About half of the UK population use complementary and alternative medicine (CAM) during their lifetimes. Yet despite this, successive governments have appeared remarkably reluctant to engage with the regulation of these therapeutic practices, despite its stated commitment to responsive and appropriate regulation of the health sector.
Date:
Thursday 12th May 2011
Categories:
Medical and Dental Sciences, Research, Social Sciences
Friday 8th April 2011

What does Additional Parental Leave mean for fathers?

Description
Fathers of children born after 3 April 2011 are entitled to take Additional Parental Leave (APL), in addition to two weeks statutory paternity leave. By allowing both (qualifying) parents to share paid parental leave, APL seemingly demonstrates a commitment to giving fathers a genuine opportunity to parent their children in the first year of life. In fact, it is not obvious that APL will make a significant difference.
Date:
Friday 8th April 2011
Categories:
Medical and Dental Sciences, Research
Monday 14th March 2011

Counting the cost of neuroscience research

Counting the cost of neuroscience research
Description
The current demographic trends show that the UK's population is becoming older. As this happens the incidence of neurodegenerative conditions like Alzheimer's, dementia and Parkinson's disease is also increasing. This has huge social, economical and political implications – further evidence that understanding how the brain works both in health and disease is a challenge that we need to address urgently before the problem of neurodegeneration becomes more evident.
Date:
Monday 14th March 2011
Categories:
Medical and Dental Sciences, Research
Wednesday 21st April 2010

Counting the cost of cancer care

Counting the cost of cancer care
Description
The UK is one of the leading centres for cancer research and clinical trials. Many of the most significant drug developments of the last decade have come through UK research.
Date:
Wednesday 21st April 2010
Displaying 9 to 12 of 13